Related Experiment Video

Updated: Aug 18, 2026

In Vivo Optical Imaging of Brain Tumors and Arthritis Using Fluorescent SapC-DOPS Nanovesicles
09:04

In Vivo Optical Imaging of Brain Tumors and Arthritis Using Fluorescent SapC-DOPS Nanovesicles

Published on: May 2, 2014

11.8K

[Juvenile idiopathic arthritis]

Florence A Aeschlimann1, Pierre Quartier1

  • 1Rhumatologie pédiatrique, hôpital Necker- Enfants malades, Paris, France.

La Revue Du Praticien
|April 16, 2019
PubMed

Insights

Juvenile idiopathic arthritis (JIA) is a common childhood rheumatic disease. Early, aggressive treatment with biologic agents improves outcomes, but lifelong monitoring is crucial.

Area of Science:

  • Pediatric Rheumatology
  • Immunology
  • Internal Medicine

Background:

  • Juvenile idiopathic arthritis (JIA) is the most prevalent chronic inflammatory rheumatic condition in childhood.
  • JIA presents as a diverse group of disorders marked by joint inflammation and potential extraarticular manifestations like uveitis.
  • Prognosis and management strategies for JIA are contingent upon the specific subtype of the disease.

Purpose of the Study:

  • To summarize the current understanding of Juvenile idiopathic arthritis (JIA).
  • To highlight recent therapeutic advancements in managing JIA.
  • To emphasize the importance of ongoing monitoring for JIA patients.

Main Methods:

  • Review of current literature on Juvenile idiopathic arthritis.
  • Analysis of recent treatment advances, including biologic agents.
  • Discussion of disease course, management, and prognosis across JIA categories.

Main Results:

  • Biologic agents have substantially decreased JIA-associated morbidity.
  • Early and aggressive therapeutic interventions are key to delaying disease progression.
  • A significant proportion of JIA cases may persist into adulthood.

Conclusions:

  • Current JIA treatment focuses on early, aggressive strategies to improve patient outcomes.
  • Despite advances, JIA often requires long-term management and careful monitoring.
  • Understanding JIA heterogeneity is vital for tailoring treatment and predicting prognosis.

Keywords:
chronic inflammatory rheumatic diseasejuvenile idiopathic arthritis

More Related Videos

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

1.1K
Refined Murine Model of Idiopathic Pulmonary Fibrosis07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

970

Related Concept Videos

Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...